Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region

BACKGROUND: Little is known of the prevalence of hepatitis B virus (HBV) infection and its effect on choice of therapy and disease course in patients with inflammatory bowel disease (IBD). We assessed the prevalence of HBV in Hong Kong as well as determinants of altered transaminases, effects of HBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Heyson C. H., Wong, Vincent W. S., Wong, Grace L. H., Tang, Whitney, Wu, Justin C. Y., Ng, Siew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994386/
https://www.ncbi.nlm.nih.gov/pubmed/27549153
http://dx.doi.org/10.1186/s12876-016-0516-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994386/
https://www.ncbi.nlm.nih.gov/pubmed/27549153
http://dx.doi.org/10.1186/s12876-016-0516-2

Ejemplares similares